BridgeBio Pharma Inc logo

BridgeBio Pharma Inc

NEW
STU:2CL (USA)  
€ 69.46 -1.54 (-2.17%) Jul 31
At Loss
Market Cap:
€ 13.61B ($ 15.71B)
Enterprise V:
€ 14.97B ($ 17.27B)
Volume:
100.00
Avg Vol (2M):
244.00
Trade In:

BridgeBio Pharma Inc (STU:2CL) Dividend

BridgeBio Pharma Inc (STU:2CL) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8.9%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: STU:2CL Dividend

Does BridgeBio Pharma Inc (STU:2CL) pay a dividend?

BridgeBio Pharma Inc (STU:2CL) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't BridgeBio Pharma Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. BridgeBio Pharma Inc has returned capital to shareholders via buybacks at a rate of -8.9% over the past 3 years.

What are dividend-paying alternatives to BridgeBio Pharma Inc?

For dividend-paying alternatives in BridgeBio Pharma Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.